Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

ClinicalTrials.gov ID: NCT04271475

Public ClinicalTrials.gov record NCT04271475. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel Group, Adaptive Phase 3 Study With Open-label Extension to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the effect of macitentan 75 mg versus placebo on exercise capacity at Week 28 in participants with chronic thromboembolic pulmonary hypertension (CTEPH).

Study identification

NCT ID
NCT04271475
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Actelion
Industry
Enrollment
127 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 7, 2020 (Actual)
Primary completion
Dec 21, 2023 (Actual)
Completion
Dec 21, 2023 (Actual)
Last update posted
Jun 27, 2025

2020 – 2023

United States locations

U.S. sites
24
U.S. states
20
U.S. cities
23
Facility City State ZIP Site status
University of California San Diego Medical Center La Jolla California 92037 —
Keck School of Medicine of USC Los Angeles California 90033 —
UC Davis Medical Center Sacramento California 95817-2201 —
University of Colorado Anschutz Medical Campus Aurora Colorado 80045 —
Yale University School Of Medicine New Haven Connecticut 06519 —
University of Florida Health Jacksonville Gainesville Florida 32608 —
Piedmont Healthcare Atlanta Georgia 30309 —
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 —
Indiana University Indianapolis Indiana 46202 —
University of Kansas Medical Center Kansas City Kansas 66160 —
University of Maryland Baltimore Maryland 21201 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Tufts Medical Center Boston Massachusetts 21118 —
University of Nebraska Medical Center Omaha Nebraska 68198-2265 —
VA Sierra Nevada Health Care System Reno Nevada 89509 —
University of New Mexico School of Medicine Albuquerque New Mexico 87131 —
Syracuse VA Medical Center Syracuse New York 13210 —
Cleveland Clinic Cleveland Ohio 44195 —
Legacy Hospital Portland Oregon 97210 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Baylor Scott White - Plano Plano Texas 75093 —
Intermountain Medical Center Murray Utah 84107 —
University of Utah Cardiovascular Center Salt Lake City Utah 84132 —
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792-2442 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 144 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04271475, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 27, 2025 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04271475 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →